Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo
- PMID: 11304496
- DOI: 10.1161/hh0701.088512
Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo
Abstract
CIS (cytokine-inducible SH2 protein), SOCS (suppressor of cytokine signaling), or SSI (signal transducers and activators of transcription [STAT]-induced STAT inhibitor) proteins are a family of cytokine-inducible negative regulators of cytokine signaling via Janus kinase (JAK)-STAT pathways. Given the evidence that the JAK-STAT pathway plays a critical role in the cardiovascular system, the primary objective of this study was to assess the effects of the CIS family on JAK-STAT signaling in the cardiovascular system in rats treated with cardiotrophin-1 (CT-1), an interleukin-6 family of cytokines. Intravenous injection of 20 microgram/kg body weight of CT-1 induced a transient, marked increase in STAT3 activation in various tissues, including heart and lung, and subsequent upregulation of 2 members of the CIS family, JAK-binding protein (JAB)/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3, in the same tissues. It was also observed that CIS3 was directly associated with JAK2 in vivo. Pretreatment with the same dose of CT-1 60 minutes before significantly attenuated the STAT3 activation induced by a second injection of CT-1. We previously reported that intravenous injection of CT-1 results in the nitric oxide (NO)-dependent hypotension accompanied by the induction of inducible NO synthase mRNA. In rats pretreated with CT-1, the induction of inducible NO synthase mRNA or hypotension by subsequent CT-1 injection was not observed. Forced expression of JAB or CIS3, but not other CISs, directly blocked CT-1-induced STAT3 activation in 293 cells. These results suggest that JAB and CIS3 serve as endogenous inhibitors of CT-1-mediated JAK-STAT signaling in the cardiovascular system in vivo.
Similar articles
-
The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.Oncogene. 2000 Sep 28;19(41):4795-801. doi: 10.1038/sj.onc.1203829. Oncogene. 2000. PMID: 11032030
-
Structure and function of a new STAT-induced STAT inhibitor.Nature. 1997 Jun 26;387(6636):924-9. doi: 10.1038/43219. Nature. 1997. PMID: 9202127
-
A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box.J Biol Chem. 2001 Nov 2;276(44):40746-54. doi: 10.1074/jbc.M106139200. Epub 2001 Aug 24. J Biol Chem. 2001. PMID: 11522790
-
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.Biochem J. 1998 Sep 1;334 ( Pt 2)(Pt 2):297-314. doi: 10.1042/bj3340297. Biochem J. 1998. PMID: 9716487 Free PMC article. Review.
-
Negative regulation of cytokine signaling pathways.Annu Rev Immunol. 2000;18:143-64. doi: 10.1146/annurev.immunol.18.1.143. Annu Rev Immunol. 2000. PMID: 10837055 Review.
Cited by
-
Role of cytokine signaling during nervous system development.Int J Mol Sci. 2013 Jul 4;14(7):13931-57. doi: 10.3390/ijms140713931. Int J Mol Sci. 2013. PMID: 23880850 Free PMC article. Review.
-
The molecular details of cytokine signaling via the JAK/STAT pathway.Protein Sci. 2018 Dec;27(12):1984-2009. doi: 10.1002/pro.3519. Protein Sci. 2018. PMID: 30267440 Free PMC article. Review.
-
MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells.Mol Med Rep. 2020 Jul;22(1):51-56. doi: 10.3892/mmr.2020.11112. Epub 2020 May 4. Mol Med Rep. 2020. PMID: 32377721 Free PMC article.
-
Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways.J Clin Invest. 2001 Nov;108(10):1459-67. doi: 10.1172/JCI13939. J Clin Invest. 2001. PMID: 11714737 Free PMC article.
-
SOCS3 deficiency in cardiomyocytes elevates sensitivity of ischemic preconditioning that synergistically ameliorates myocardial ischemia reperfusion injury.PLoS One. 2021 Jul 22;16(7):e0254712. doi: 10.1371/journal.pone.0254712. eCollection 2021. PLoS One. 2021. PMID: 34292971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous